Company logo

SAVA - Cassava Sciences, Inc.

NASDAQ -> Healthcare -> Biotechnology
Austin, United States
Type: Equity

SAVA price evolution
SAVA
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Current assets
Cash $207.29 $124.17 $121.14
Short term investments
Net receivables $1.27 $1.43 $1 $0.96
Inventory
Total current assets $202.55 $222.12 $134 $129.63
Long term investments
Property, plant & equipment $21.14 $21.36 $21.6 $21.85
Goodwill & intangible assets $0.08 $0.12 $0.18
Total noncurrent assets $21.45 $21.72 $22.03
Total investments
Total assets $223.75 $243.57 $155.72 $151.66
Current liabilities
Accounts payable $52.24 $52.55 $9.6 $10.57
Deferred revenue
Short long term debt
Total current liabilities $57.03 $54.59 $77.12 $14.2
Long term debt
Total noncurrent liabilities
Total debt
Total liabilities $57.11 $54.59 $77.12 $14.2
Shareholders' equity
Retained earnings -$377.51 -$349.57 -$355.73 -$380.77
Other shareholder equity
Total shareholder equity $188.97 $78.6 $137.47
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $121.14 $201.01 $233.44 $93.51
Short term investments
Net receivables $0.96
Inventory
Total current assets $129.63 $211.23 $244.48 $93.99
Long term investments
Property, plant & equipment $21.85 $22.99 $20.83 $0.31
Goodwill & intangible assets $0.18 $0.62 $1.07
Total noncurrent assets $22.03 $23.61 $22.3 $0.31
Total investments
Total assets $151.66 $234.83 $266.78 $94.3
Current liabilities
Accounts payable $10.57 $4.02 $7.13 $0.91
Deferred revenue
Short long term debt $0.1 $0.1 $0.06
Total current liabilities $14.2 $7.06 $12.53 $1.86
Long term debt $0.04 $0.14 $0.23
Total noncurrent liabilities $0.23 $0.33 $0.23
Total debt $0.14 $0.24 $0.29
Total liabilities $14.2 $7.29 $12.87 $2.1
Shareholders' equity
Retained earnings -$380.77 -$283.55 -$207.31 -$174.92
Other shareholder equity
Total shareholder equity $137.47 $227.54 $253.91 $92.2
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $15.2 $16.23 $18.73
Selling, general & administrative $46.2 $3.7 $4.06
Total operating expenses $61.4 $19.93 $22.79
Operating income -$61.4 -$19.93 -$22.79
Income from continuing operations
EBIT $6.16 $25.04 -$20.92
Income tax expense
Interest expense
Net income
Net income $6.16 $25.04 -$20.92
Income (for common shares) $6.16 $25.04 -$20.92
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $89.42 $68.03 $24.81 $3.05
Selling, general & administrative $16.53 $11.99 $8.05 $3.74
Total operating expenses $105.96 $80.02 $32.87 $6.45
Operating income -$105.96 -$80.02 -$32.87 -$6.45
Income from continuing operations
EBIT -$97.22 -$76.25 -$32.38 -$6.33
Income tax expense
Interest expense
Net income
Net income -$97.22 -$76.25 -$32.38 -$6.33
Income (for common shares) -$97.22 -$76.25 -$32.38 -$6.33
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Net income $6.16 $25.04 -$20.92
Operating activities
Depreciation $0.3 $0.31 $0.36
Business acquisitions & disposals
Stock-based compensation $2.6 $2.33 $2.13
Total cash flows from operations -$18.24 -$19.13 -$22.32
Investing activities
Capital expenditures -$0.03 -$0.04
Investments
Total cash flows from investing -$0.05 -$0.03 -$0.04
Financing activities
Dividends paid
Sale and purchase of stock $101.39 $22.16 $1.14
Net borrowings
Total cash flows from financing $123.55 $101.39 $22.16 $1.14
Effect of exchange rate
Change in cash and equivalents $67.84 $83.12 $3.03 -$21.21
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$97.22 -$76.25 -$32.38 -$6.33
Operating activities
Depreciation $1.53 $1.3 $0.53 $0.02
Business acquisitions & disposals
Stock-based compensation $4.59 $2.07 $1.76 $0.99
Total cash flows from operations -$82.03 -$77.51 -$30.2 -$5.38
Investing activities
Capital expenditures -$0.41 -$2.71 -$22.21 $0.36
Investments
Total cash flows from investing -$0.41 -$2.71 -$22.21 $0.36
Financing activities
Dividends paid
Sale and purchase of stock $2.56 $47.8 $192.34 $75.45
Net borrowings
Total cash flows from financing $2.56 $47.8 $192.34 $75.45
Effect of exchange rate
Change in cash and equivalents -$79.88 -$32.42 $139.93 $70.42
Fundamentals
Market cap $110.82M
Enterprise value N/A
Shares outstanding 47.98M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.10
Net debt/EBITDA N/A
Current ratio 3.55
Quick ratio N/A